Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2022 | Story André Damons | Photo Jack once productions
The three directors of Epicutis Skincare
All smiles. The three directors of Epicutis Skincare; Dr Maanda Tshikororo, Chief Marketing Officer; Dr Lehlohonolo Makhakhe, Chief Executive officer and primary formulation scientist; and Mrs Mantwa Makhakhe, Chief Operating Officer, showing of some of their new skincare products

A senior lecturer and specialist in the Department of Dermatology at the University of the Free State (UFS) and his two associates, who are also postgraduate students at the university, have realised their dream when they launch their skincare company next month.
 

Dr Lehlohonolo Makhakhe, a full-time medical specialist (dermatologist), Dr Maanda Tshikororo, a medical doctor and a postgraduate student in the Department of Psychiatry, and Mrs Mantwa Makhakhe, who holds a BCom Economics degree and is currently completing her postgraduate diploma in financial planning, are the directors of Epicutis Skincare. Dr Makhakhe, who is also a PhD candidate registered with UFS, is the Chief Executive Officer and primary formulation scientist for the company, while Dr Tshikororo is the Chief Marketing Officer and Mrs Makhakhe the Chief Operating Officer.

The company is launching on 22 October 2022.

Narrowing the gap between treating skin ailments and manufacturing skincare products

According to Dr Makhakhe, who published the very first comprehensive African atlas on skin diseases commonly seen in the African setting,The African Atlas, synopsis and practical guide to clinical dermatology, says Epicutis is a company which will produce a range of personal skincare products. The range will comprise of products such as body lotions, body creams, petroleum jelly and a night cream. Since becoming a dermatologist, he has always wished to narrow the gap between being a clinician treating skin ailments and being involved in manufacturing skincare products.

“Creating products as a dermatologist has great benefits, because the products are created from a clinician’s perspective, with more intentional results. All ingredients used were carefully selected for their specific and scientifically proven benefits, they were then tested for stability in terms of viscosity, pH, microbiology in association with the South African Institute of Dermatology and other third parties,” says Dr Makhakhe. 

Ecstatic about the upcoming launch

Dr Tshikororo says this has been an adventure they have always thought of undertaking. “We finally reached a point of shifting from the comfort of dreaming about it, to taking action.” 

“We hope our company will play a notable role in creating permanent employment for the youth, and also have an impact on the growth of the economy of the Free State province and that of the country as well,” says Mrs Makhakhe. 
The three directors are ecstatic about the upcoming launch of their products, and optimistic that there is enough room for new, affordable, locally manufactured skincare products that are suitable for all family members.  

All products will be available at major retailers soon after the launch. Further information is available at the official website

News Archive

Researcher shares platform with Nobel Laureate at conference on nanomedicine
2013-01-10

Prof. Lodewyk Kock at the Everest viewpoint with Mount Everest behind him.
10 January 2013

Profs. Lodewyk Kock and Robert Bragg from the Department of Microbial, Biochemical and Food Biotechnology at the University of the Free State (UFS) both presented lectures at the first International Conference on Infectious Diseases and Nanomedicine that was held in Kathmandu, Nepal, late last year.

At the conference, also attended by senior representatives from the International Union of Microbiological Societies (IUMS), Prof. Kock delivered one of the two opening lectures, titled: Introducing New Nanotechnologies to Infectious Diseases (the other opening lecture was presented by Nobel Laureate, Prof. Barry J. Marshal). Prof. Kock also participated in the farewell address.

In two excellent lectures, Prof. Bragg spoke on Bacteriophages as potential treatment option of antibiotic-resistant bacteria, and on Bacterial resistance to quaternary ammonium compounds.

For Prof. Kock this very first conference on infectious diseases and nanomedicine was followed by a very exciting yeast research excursion through the Mount Everest Highway which winds through the villages of the Sherpa tribe.

He describes his journey: “The Mount Everest Highway is a rough road stretching through hills and glacial moraines of unfamiliar altitudes and cold temperatures. Throughout the journey I had to take care of not contracting altitude sickness which causes severe headaches and dizziness.

“The only way of transport is on foot, on long-haired cattle called Yaks, donkeys and by helicopter. After flying by plane from Kathmandu (the capital of Nepal), I landed at Lukla, regarded as the most dangerous airport in the world due to its short elevated runway and mountainous surroundings. From Lukla, the land of the Sherpa, I walked (trekked) with my Sherpa guide and porter (carrier) along the Everest Highway surrounded by various Buddhist Mani scripture stands, other Buddhist representations and many spectacular snow-tipped mountains of more than 6 000 m above sea level. Of these, the majestic mountain called Ama Dablam (6 812 m), the grand 8 516 m high peak of Lhotse and to its left the renowned Mount Everest at 8 848 m in height, caught my attention.

“Dwarfed by these mountain peaks on the horizon, I passed various villages until I eventually reached the beautiful village called Namche Bazar, the heart of the Khumbu region and hometown of the Sherpa. This took three days of up to six hours walking per day, while I spent the nights at the villages of Phakding and Monjo. From there I walked along the Dudh Kosi River which stretches towards Mount Everest, until I reached the high altitude Everest viewpoint – the end of my journey, after which I trekked back to Lukla to return to Kathmandu and South Africa.

“This expedition is the first exploration to determine the presence of yeasts in the Everest region. Results from this excursion will be used in collaborative projects with local universities in Nepal that are interested in yeast research.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept